
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design and Discovery of Novel NLRP3 Inhibitors and PET Imaging Radiotracers Based on a 1,2,3-Triazole-Bearing Scaffold
Yiming Xu, Yulong Xu, Savannah Biby, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 555-571
Open Access | Times Cited: 6
Yiming Xu, Yulong Xu, Savannah Biby, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 555-571
Open Access | Times Cited: 6
Showing 6 citing articles:
Design, Synthesis, and Biological Evaluation of Ferulic Acid-Piperazine Derivatives Targeting Pathological Hallmarks of Alzheimer’s Disease
Gourav Singh, Sunil Kumar, Samir Ranjan Panda, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 15, pp. 2756-2778
Closed Access | Times Cited: 3
Gourav Singh, Sunil Kumar, Samir Ranjan Panda, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 15, pp. 2756-2778
Closed Access | Times Cited: 3
Synthesis and applications of fluorinated, polyfluoroalkyl- and polyfluoroaryl-substituted 1,2,3-triazoles
Frances E. Bugden, Joanna Westwood, H. E. N. Stone, et al.
Organic Chemistry Frontiers (2024) Vol. 11, Iss. 20, pp. 5938-5984
Open Access | Times Cited: 3
Frances E. Bugden, Joanna Westwood, H. E. N. Stone, et al.
Organic Chemistry Frontiers (2024) Vol. 11, Iss. 20, pp. 5938-5984
Open Access | Times Cited: 3
Discovery of novel substituted (Z)-N'-hydroxy-3-(3-phenylureido)benzimidamide derivatives as multifunctional molecules targeting pathological hallmarks of Alzheimer’s disease
Gauri Shankar, C. Praveen Kumar, M. K. Yadav, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116959-116959
Closed Access | Times Cited: 1
Gauri Shankar, C. Praveen Kumar, M. K. Yadav, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116959-116959
Closed Access | Times Cited: 1
Functional Characterization of an Arylsulfonamide-Based Small-Molecule Inhibitor of the NLRP3 Inflammasome
Savannah Biby, Prasenjit Mondal, Yiming Xu, et al.
ACS Chemical Neuroscience (2024)
Open Access
Savannah Biby, Prasenjit Mondal, Yiming Xu, et al.
ACS Chemical Neuroscience (2024)
Open Access
Synthesis, biological evaluation and molecular dynamics simulations of new sulfonylurea derivatives bearing biphenyl moieties as potential NLRP3 inhibitors
Xin Xiong, Ruifeng Zhang, Zhijian Min, et al.
Research on Chemical Intermediates (2024) Vol. 50, Iss. 12, pp. 5863-5883
Closed Access
Xin Xiong, Ruifeng Zhang, Zhijian Min, et al.
Research on Chemical Intermediates (2024) Vol. 50, Iss. 12, pp. 5863-5883
Closed Access
Biological and therapeutic significance of targeting NLRP3 inflammasome in the brain and the current efforts to develop brain-penetrant inhibitors
Baljit Kaur, Savannah Biby, Jannatun Nayem Namme, et al.
Advances in pharmacology (2024), pp. 103-157
Closed Access
Baljit Kaur, Savannah Biby, Jannatun Nayem Namme, et al.
Advances in pharmacology (2024), pp. 103-157
Closed Access